MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway
Abstract Growing evidence underscores the pivotal impact of crosstalk between leukemic stem cells (LSCs) and mesenchymal stromal cells (MSCs) within their niche on leukemia initiation, progression, and therapy response. Although MMP14 plays an important role in inflammation and cancer, the regulatio...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-03-01
|
| Series: | Experimental Hematology & Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s40164-025-00635-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850057436290875392 |
|---|---|
| author | Jinxian Wu Xinqi Li Yin Liu Guopeng Chen Ruihang Li Hongqiang Jiang Wanyue Yin Xiqin Tong Rui Cao Xianwang Wang Xiaoyan Liu Fuling Zhou |
| author_facet | Jinxian Wu Xinqi Li Yin Liu Guopeng Chen Ruihang Li Hongqiang Jiang Wanyue Yin Xiqin Tong Rui Cao Xianwang Wang Xiaoyan Liu Fuling Zhou |
| author_sort | Jinxian Wu |
| collection | DOAJ |
| description | Abstract Growing evidence underscores the pivotal impact of crosstalk between leukemic stem cells (LSCs) and mesenchymal stromal cells (MSCs) within their niche on leukemia initiation, progression, and therapy response. Although MMP14 plays an important role in inflammation and cancer, the regulation and role of MSC-derived MMP14 in acute myeloid leukemia (AML) are largely unknown. Here, we found that AML patient-derived MSCs (AML-MSCs) were more supportive of AML cell growth compared to healthy donor-derived MSCs (HD-MSCs). Moreover, AML-MSCs and HD-MSCs showed significant differences in gene expression and protein expression profiles. Knockdown of MMP14 in MSCs inhibited the CFU-F ability of MSC cells and increased the proportion of cells in the G0 phase, thereby inhibiting proliferation. Co-culture with MSCs inhibited the proliferation and cell cycle progression of leukemia cells, while increasing the apoptosis rate, thus impairing the leukemogenic potential of AML cells both in vitro and in vivo. Mechanistic studies revealed that MMP14-mediated alterations in the AML stromal microenvironment are driven by PGE2 secretion and activation of the JAK-STAT pathway, promoting leukemia progression. Notably, inhibition of MMP14 can attenuate the chemotherapy resistance of AML cells induced by MSCs to cytarabine (Ara-C). Together, our study, for the first time, demonstrates the critical role of MSC-derived MMP14 in promoting AML progression and chemoresistance. Targeting MMP14 signaling pathways may offer novel therapeutic options for AML. |
| format | Article |
| id | doaj-art-5ea63dc700aa4d09886d9d3d3524c697 |
| institution | DOAJ |
| issn | 2162-3619 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Experimental Hematology & Oncology |
| spelling | doaj-art-5ea63dc700aa4d09886d9d3d3524c6972025-08-20T02:51:27ZengBMCExperimental Hematology & Oncology2162-36192025-03-0114111810.1186/s40164-025-00635-6MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathwayJinxian Wu0Xinqi Li1Yin Liu2Guopeng Chen3Ruihang Li4Hongqiang Jiang5Wanyue Yin6Xiqin Tong7Rui Cao8Xianwang Wang9Xiaoyan Liu10Fuling Zhou11Department of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Biochemistry and Molecular Biology, Center for Molecular Medicine, Health Science Center, Yangtze UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityDepartment of Hematology, Zhongnan Hospital of Wuhan UniversityAbstract Growing evidence underscores the pivotal impact of crosstalk between leukemic stem cells (LSCs) and mesenchymal stromal cells (MSCs) within their niche on leukemia initiation, progression, and therapy response. Although MMP14 plays an important role in inflammation and cancer, the regulation and role of MSC-derived MMP14 in acute myeloid leukemia (AML) are largely unknown. Here, we found that AML patient-derived MSCs (AML-MSCs) were more supportive of AML cell growth compared to healthy donor-derived MSCs (HD-MSCs). Moreover, AML-MSCs and HD-MSCs showed significant differences in gene expression and protein expression profiles. Knockdown of MMP14 in MSCs inhibited the CFU-F ability of MSC cells and increased the proportion of cells in the G0 phase, thereby inhibiting proliferation. Co-culture with MSCs inhibited the proliferation and cell cycle progression of leukemia cells, while increasing the apoptosis rate, thus impairing the leukemogenic potential of AML cells both in vitro and in vivo. Mechanistic studies revealed that MMP14-mediated alterations in the AML stromal microenvironment are driven by PGE2 secretion and activation of the JAK-STAT pathway, promoting leukemia progression. Notably, inhibition of MMP14 can attenuate the chemotherapy resistance of AML cells induced by MSCs to cytarabine (Ara-C). Together, our study, for the first time, demonstrates the critical role of MSC-derived MMP14 in promoting AML progression and chemoresistance. Targeting MMP14 signaling pathways may offer novel therapeutic options for AML.https://doi.org/10.1186/s40164-025-00635-6Acute myeloid leukemiaMesenchymal stromal cellsMMP14JAK/STAT pathwayPGE2 |
| spellingShingle | Jinxian Wu Xinqi Li Yin Liu Guopeng Chen Ruihang Li Hongqiang Jiang Wanyue Yin Xiqin Tong Rui Cao Xianwang Wang Xiaoyan Liu Fuling Zhou MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway Experimental Hematology & Oncology Acute myeloid leukemia Mesenchymal stromal cells MMP14 JAK/STAT pathway PGE2 |
| title | MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway |
| title_full | MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway |
| title_fullStr | MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway |
| title_full_unstemmed | MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway |
| title_short | MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway |
| title_sort | mmp14 from bm mscs facilitates progression and ara c resistance in acute myeloid leukemia via the jak stat pathway |
| topic | Acute myeloid leukemia Mesenchymal stromal cells MMP14 JAK/STAT pathway PGE2 |
| url | https://doi.org/10.1186/s40164-025-00635-6 |
| work_keys_str_mv | AT jinxianwu mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT xinqili mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT yinliu mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT guopengchen mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT ruihangli mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT hongqiangjiang mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT wanyueyin mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT xiqintong mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT ruicao mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT xianwangwang mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT xiaoyanliu mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway AT fulingzhou mmp14frombmmscsfacilitatesprogressionandaracresistanceinacutemyeloidleukemiaviathejakstatpathway |